-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$108.2524.51% Upside
Haemonetics Corporation Frequently Asked Questions
-
What analysts cover Haemonetics Corporation?
Haemonetics Corporation has been rated by research analysts at Raymond James, C.L. King, Bank of America Securities, Needham in the past 90 days.